Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy

Cover Page

Cite item

Full Text

Abstract

Therapy results of 91 patients with newly diagnosed multiple myeloma who received autologous hematopoietic stem cells transplantation are presented. According to our data, survival depends on the preransplant response and the amount of transplantations. 5-years progressionfree survival in patients, achieved pre-transplant complete or almost complete remission and received one auto-HSCT was 40 % compared with 18 % in patients who achieved only a partial response (p = 0.07). 10-years overall survival in patients received tandem auto-HSCT was
40 % compared with 20 % in patients after one auto-HSCT. Statistically significant differences in 5-years progression-free survival (34 % after tandem auto-HSCT vs. 22 % after one auto-HSCT; p = 0.004) also were revealed.

About the authors

Ye. I. Darskaya

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: edarskaya@mail.ru
Russian Federation

N. E. Marami-Zonuzi

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

Yu. S. Osipov

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

M. A. Estrina

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

Ye. V. Babenko

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

V. N. Vavilov

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

B. V. Afanasiev

Raisa Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation, I.P. Pavlov First St.-Petersburg State Medical University, Ministry of Health of Russia

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.